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In 2009, the Tennessee Department of Health 
received reports of 5 tuberculin skin test (TST) conversions 
among employees of an elephant refuge and isolation of 
Mycobacterium tuberculosis from a resident elephant. 
To determine the extent of the outbreak and identify risk 
factors for TST conversion, we conducted a cohort study 
and onsite assessment. Risk for conversion was increased 
for elephant caregivers and administrative employees 
working in the barn housing the M. tuberculosis–infected 
elephant or in ofﬁ  ces connected to the barn (risk ratio 20.3, 
95% conﬁ   dence interval 2.8–146.7). Indirect exposure to 
aerosolized  M. tuberculosis and delayed or inadequate 
infection control practices likely contributed to transmission. 
The following factors are needed to reduce risk for M. 
tuberculosis transmission in the captive elephant industry: 
increased knowledge about M. tuberculosis infection in 
elephants, improved infection control practices, and speciﬁ  c 
occupational health programs.
Z
oonotic transmission of Mycobacterium tuberculosis 
from elephants to humans working in close proximity 
was described in the late 1990s. Studies of workers 
exposed to elephants infected with M. tuberculosis have 
reported a potential for elevated risk among those who 
have prolonged and close contact with elephants; engage in 
treatment, medical procedures, or necropsies of elephants; 
live inside or close to an elephant barn; or participate in 
cleaning elephant barns or work as groundskeepers (1–3).
In North America, ≈270 Asian and ≈220 African 
elephants live in captivity (4,5), most in facilities accredited 
by the Association of Zoos and Aquariums and the rest in 
public, private, and nonproﬁ  t facilities. Among these, ≈12% 
of Asian and ≈2% of African elephants are thought to be 
infected with M. tuberculosis (6,7). Recommendations for 
detection and treatment of tuberculosis (TB) in elephants 
exist (8). However, no standard deﬁ  nition exists for latent 
TB in elephants, and no sound clinical criteria exist for 
diagnosing TB in elephants. Elephants are considered 
exposed to M. tuberculosis if they have had contact with an 
M. tuberculosis culture–positive animal. They are thought 
to have active TB when M. tuberculosis is cultured from 
respiratory secretions obtained from their trunk (trunk 
wash). However, performing a trunk wash is challenging, 
and culture of M. tuberculosis from these specimens is 
unreliable (9,10). Knowledge about effectiveness of human 
antituberculous medications in elephants is limited (6–8).
We describe an outbreak of M. tuberculosis infection 
among employees of an elephant refuge. We also present 
ﬁ  ndings of the ensuing epidemiologic and environmental 
investigation conducted to identify work practices and 
facility characteristics that probably contributed to zoonotic 
transmission.
Outbreak
In July 2009, routine screening detected conversion 
of tuberculin skin test (TST) results from negative to 
positive among caregivers at a nonproﬁ  t elephant refuge in 
south-central Tennessee, USA. In addition, records review 
revealed that respiratory secretions obtained by trunk 
wash of a quarantined elephant (elephant L) in December 
2008 contained M. tuberculosis. To determine the extent 
of the outbreak, identify risk factors for TST conversion 
among humans, and develop strategies to prevent ongoing 
zoonotic transmission, we conducted an investigation.
Setting
The elephant refuge was established in 1995 with 
the mission of caring for sick, old, or abused elephants 
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transferred from private owners, zoos, and circuses. It 
operates on 2,700 acres divided by fences into 3 distinct 
areas, each having its own barn. Elephants graze outdoors 
during the day and might be enclosed in barns at night, 
particularly during cold or inclement weather. At the time 
of the outbreak, 1 area housed 2 African elephants; 1 area 
housed 6 Asian elephants; and a third area housed 7 Asian 
elephants in a large quarantine barn connected to a 2-story 
administrative support building. The refuge is accredited 
by the Association of Sanctuaries and licensed by the 
United States Department of Agriculture (USDA) and 
the Tennessee Wildlife Resources Agency (TWRA); it is 
closed to the public.
In 2004, the refuge received, from an exotic animal 
farm in Illinois, 2 female Asian elephants with a history 
of active TB. The transfer of M. tuberculosis culture–
positive elephants into Tennessee was contingent upon 
adherence to the USDA-endorsed Guidelines for the 
Control of Tuberculosis in Elephants (8) and an infection 
control plan set forth by TWRA in consultation with the 
Tennessee Department of Health (TDH). One elephant died 
of TB in 2005; the other was treated with antituberculous 
medications for 1 year and was released from isolation in 
accordance with the guidelines.
In 2006, the refuge accepted 8 additional elephants 
from the same exotic animal farm in Illinois. Although 
none were known to have active TB, they were considered 
exposed and at high risk for latent M. tuberculosis infection 
because they had been housed with M. tuberculosis culture–
positive elephants. In accordance with the guidelines, all 
8 were quarantined when they arrived in Tennessee, and 
respiratory secretions obtained by trunk wash were tested 
annually for M. tuberculosis. In 2008, one died of causes 
unrelated to TB.
Investigation
Information and records provided by the refuge and 
TWRA were used to construct a historical timeline of 
key events for employees and resident elephants. Onsite 
evaluations of barn management and husbandry practices 
were conducted.
Elephants at the refuge had been trained to give 
respiratory secretions that were used for culture isolation 
of M. tuberculosis by a triple-sample trunk-wash method 
(8). Brieﬂ  y, 30–60 mL of sterile saline was instilled into the 
elephant’s trunk. The elephant raised and then lowered its 
trunk to drain or exhale the saline into a plastic bag. Three 
samples obtained on separate mornings within 1 week were 
processed by using standard methods for culture isolation 
of mycobacteria (11).  M. tuberculosis isolates obtained 
from elephant respiratory secretions were genotyped by 
using standard methods recommended by the Centers 
for Disease Control and Prevention (CDC). Results were 
compared with others stored in the CDC TB Genotyping 
Information Management System.
A retrospective cohort study was conducted to 
identify risk factors for M. tuberculosis infection among 
employees who worked at the elephant refuge during 
2006–2009. One investigator interviewed current 
employees in person and former employees by telephone. 
Employees were asked about potential risk factors 
for  M. tuberculosis exposure, history of TSTs and M. 
tuberculosis infection, work assignments and practices, 
training and use of personal protective equipment, and 
close contact with elephants. Close contact was deﬁ  ned 
as touching or being close enough to touch an elephant. 
TST results, employment history, and N95 respirator ﬁ  t-
testing dates were veriﬁ  ed by checking employee records 
at the refuge.
A preemployment TST was required for elephant 
caregivers, and all employees received annual TST 
screening. For employees with a documented negative (<10 
mm) TST result, a >10 mm increase in induration within 
2 years was considered a TST conversion indicative of 
recent infection with M. tuberculosis (12–14). Employees 
whose TST results converted were evaluated for latent 
M. tuberculosis infection or active TB at local health 
departments or by private clinicians.
Environmental samples were collected from the barn 
housing the M. tuberculosis–infected elephant. These 
included elephant feces (triplicate samples of 10 g each), 
water from drinking troughs (triplicate samples of 45 
mL each), and swabs of barn surfaces (e.g., duplicate or 
triplicate samples collected from walls, ﬂ  oors, gates, and 
drains by using a 3M Sponge-Stick with neutralizing buffer 
[3M, St. Paul, MN, USA]). Samples were processed by 
TDH Laboratory Services according to standard methods 
for culture isolation of mycobacteria (11). A theatrical 
smoke machine was used to enable visualization of air ﬂ  ow 
patterns within and between the barn and administrative 
support areas.
Statistical analyses were performed by using SAS 
version 9.1 (SAS Institute Inc., Cary, NC, USA). CDC 
human subjects review classiﬁ  ed this work as public health 
evaluation and control.
Findings
All trunk-wash specimens obtained from elephants at 
the refuge during 2006–2009 had negative M. tuberculosis 
culture results except for specimens taken in December 
2008 from 1 elephant living in the quarantine area (elephant 
L). M. tuberculosis culture–positive results were received 
in March 2009. In July 2009, sampling was repeated and 
culture-positive results were conﬁ  rmed. Infection control 
practices were heightened in October 2009. In 2010, 
treatment of elephant L with antituberculous medication 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 3, March 2011  367RESEARCH
began but was complicated by the elephant’s intolerance to 
both oral and rectal medical therapy.
M. tuberculosis isolated from elephant L was 
susceptible to isoniazid, rifampin, ethambutol, 
pyrazinamide, and streptomycin and had genotype 
PCR01621. TDH records indicated that genotype 
PCR01621 had also been isolated from 2 elephants that 
had died with TB at the refuge in 2005 and 2006. All 3 
elephants had spent time at the same exotic animal farm in 
Illinois, and at least 1 was among the elephants involved 
in a 1996 outbreak (2). M. tuberculosis PCR01621 was 
also isolated from an elephant in Missouri in 2008 and 
from a human patient who received a diagnosis of active 
TB in 2004. The human patient lived in California at the 
time of diagnosis; his potential for exposure to captive 
elephants was unknown.
Of 57 refuge employees, 46 (81%) were contacted 
(25 current and 21 former employees). Interviews were 
conducted with these 30 caregivers, 11 administrators, and 
5 maintenance workers. Eleven former employees could 
not be reached. The average age of respondents was 38 
years (range 20–65 years); 31 (67%) were female. All had 
at least 1 previous negative TST result; 9 had TST results 
that converted during 2006–2009 (indurations 12–24 mm), 
although none were identiﬁ  ed as having active TB.
Relative risk estimates for traditional risk factors 
for TST conversion among refuge employees were not 
statistically signiﬁ   cant (Table 1). No human source of 
M. tuberculosis at the refuge was identiﬁ  ed.  However, 
employees who worked in the quarantine area during 2009 
were signiﬁ  cantly more likely than those who did not work 
there during that period to convert (risk ratio 20.3; 95% 
conﬁ  dence interval 2.8–146.7). One employee converted in 
2006 after close, prolonged contact with the elephant that 
died with TB in 2005. The other 8 converted during 2009 
and had worked in the quarantine area for >4 hours that 
year. Therefore, we separately examined characteristics of 
all 13 employees who worked in the quarantine area for 
>4 hours during 2009 and observed their work practices in 
more detail (Figure).
Among these 13 employees, only 1 who converted 
had close contact with any elephant (Table 2). Compared 
with employees who did not convert, fewer employees who 
converted reported always wearing an N95 respirator when 
indicated or having the ﬁ  t of the respirator tested annually.
Also among these 13 employees, 5 were elephant 
caregivers, 2 were maintenance workers, and 3 were 
administrators. Caregivers and maintenance workers 
engaged in aerosol-generating work practices during 
quarantine barn maintenance. Hay, sawdust, and excrement 
were swept or shoveled from elephant stalls and yards every 
day. In addition, the entire barn was cleaned every day with 
a high-pressure water sprayer. This practice created a dense 
mist that visibly lingered in the enclosed barn for hours. 
Although respirators were indicated for persons working 
inside the quarantine barn, construction of the barn allowed 
unﬁ  ltered air to ﬂ  ow between the barn and the adjacent 
2-story administrative support areas where respirators were 
not worn. These administrative areas included space for 
barn storage, elephant food preparation, and data entry; 
a restroom on the ﬁ  rst ﬂ  oor; and an ofﬁ  ce on the second 
ﬂ  oor. All 3 administrators who worked in these areas had 
no direct contact with elephants, but their TST results 
converted.
M. tuberculosis was not isolated from 52 samples 
collected from the environment of elephant L. M. 
fortuitum complex was identiﬁ  ed in fecal samples from 2 
elephants, a water sample, and surface swabs of a watering 
trough and 2 barn drains. Studies using theatrical smoke 
conﬁ  rmed that air was shared between the barn and the 
2-story administrative support area under normal working 
conditions.
The refuge infection control plan was intended for 
implementation when an M. tuberculosis culture–positive 
elephant was in residence. Before arrival of the 2 culture-
positive elephants in 2004, employees had received 
training on the risk for M. tuberculosis transmission from 
elephants to humans, and the refuge established respiratory 
protection and TST screening programs. By the end of 
2005, all elephants living at the refuge were M. tuberculosis 
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Table 1. Exact relative risk for potential risk factors for Mycobacterium tuberculosis infection among 46 elephant refuge employees, 
Tennessee, USA, 2009* 
Potential risk factor 
TST conversion/ 
risk factor, no. (%) 
TST conversion/ 
no risk factor, no. (%)  Relative risk (95% CI)† 
Foreign born  2/6 (33)  7/40 (18)  1.91 (0.51–7.10) 
International travel past 5 y  5/19 (26)  4/27 (14)  1.78 (0.58–5.76) 
Exposure to person(s) with TB  0/4 (0)  9/42 (21)  NC 
Previous health care facility work  1/8 (13)  8/38 (21)  0.59 (0.09–4.10) 
Previous correctional facility work  0/4 (0)  9/42 (21)  NC 
Previous homeless shelter work  0/1 (0)  9/45 (20)  NC 
Close contact with elephant(s)  2/11 (18)  7/35 (20)  0.91 (0.22–3.75) 
Quarantine area exposure during 2009  8/13 (62)  1/33 (3)  20.31 (2.81–146.69) 
*TST, tuberculin skin test; CI, confidence interval; TB, tuberculosis; NC, not computed. 
†Relative risk and confidence intervals were not computed when at least 1 cell contained zero. Elephant-to-Human Transmission of Tuberculosis
culture negative. Subsequently, formal employee training 
was discontinued, and infection control procedures 
were not strictly followed. The refuge continued single 
preemployment TST screening for elephant caregivers and 
annual TST screening for all employees.
Discussion
Epidemiologic and observational data indicate that 
M. tuberculosis was transmitted from an elephant with 
active TB to humans working at the elephant refuge. 
Employees who worked >4 hours in the quarantine barn 
during 2009 were 20× more likely to have latent M. 
tuberculosis infection than those who did not. TST results 
for refuge employees without quarantine barn exposure 
in 2009 did not convert. Risk for employees working in 
the quarantine area was probably increased by delayed 
response and failure to enhance infection control practices 
after obtaining M. tuberculosis culture–positive results for 
elephant L. Notably, close contact with elephant L was 
not required for transmission. Caregivers and maintenance 
workers probably aerosolized M. tuberculosis that had 
been expelled or excreted by elephant L while they cleaned 
soiled barn surfaces. For example, pressure washing 
created an impressively dense mist that lingered in the barn 
throughout the day. The mist was not contained within the 
barn and mixed with air in the connected administrative 
support areas where respirators were never worn, thus 
providing a route of indirect M. tuberculosis transmission 
for the 3 administrative workers who reported no contact 
with elephant L. The hypothesis of indirect transmission 
is further supported by the TST conversion of a study 
investigator who spent limited time in the administrative 
support area before the risk was recognized and 
interventions were implemented.
During the 19th and 20th centuries, disease caused by 
M. tuberculosis among captive elephants living in Asia, 
Europe, and North America was sporadically reported (14–
19). The ﬁ  rst reported outbreak of TB among elephants in 
North America occurred at an exotic animal farm in Illinois 
in 1996 (2). The investigation identiﬁ  ed evidence of M. 
tuberculosis infection in 4 Asian elephants (3 of which 
died) and 11 elephant caregivers (1 of whom had active 
TB). The event prompted action from USDA, and since 
1998, the USDA Animal Plant Health Inspection Service 
has required annual M. tuberculosis testing by the trunk-
wash–culture method for all captive elephants in the United 
States (20).
Analogous to culture-positive sputum in human 
patients, an M. tuberculosis culture-positive trunk wash 
from an elephant is considered the standard for conﬁ  rming 
active TB disease. However, active TB disease and 
shedding of M. tuberculosis organisms cannot be excluded 
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Table 2. Exact relative risk for potential risk factors for latent Mycobacterium tuberculosis infection among 13 employees who worked 
in the quarantine area of an elephant refuge, Tennessee, USA, 2009* 
Potential risk factor 
TST conversion/ 
risk factor, no. (%) 
TST conversion/ 
no risk factor, no. (%)  Relative risk (95% CI)† 
Close contact with elephant(s)  1/3 (33)  7/10 (70)  0.48 (0.09–2.48) 
Participated in elephant trunk washes  0/1 (0)  8/12 (67)  NC 
Pressure washed barn walls and floors  5/8 (63)  3/5 (60)  1.04 (0.43–2.55) 
N95 respirator fit tested annually  2/5 (40)  6/8 (75)  0.53 (0.17–1.68) 
“Always” compliant with N95 wear  2/5 (40)  6/8 (75)  0.53 (0.17–1.68) 
*TST, tuberculin skin test; CI, confidence interval; NC, not computed. 
†Relative risk and confidence intervals were not computed when at least 1 cell contained zero. 
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Figure. Tuberculin skin test (TST) 
conversion timeline for 13 employees 
who worked in the quarantine area of 
an elephant refuge, Tennessee, USA, 
2009. Gray, exposure to quarantine barn; 
black, negative TST result; red, positive 
TST result; yellow, elephant L positive for 
Mycobacterium tuberculosis.RESEARCH
with a culture-negative trunk-wash result because the test 
has low sensitivity (9,10,21).
Considerable effort has gone toward developing 
methods for early and reliable diagnosis of latent M. 
tuberculosis infection among elephants. TST is unreliable 
(10), but serum antibody tests appear promising (9,22). 
Although serologic tests can detect infection with M. 
tuberculosis years earlier than trunk-wash cultures (9), 
negative serologic results cannot exclude the possibility 
of infection. In February 2010, USDA added serologic 
testing (ElephantTB STAT PAK Kit; Chembio Diagnostic 
Systems, Inc., Medford, NY, USA) to its annual trunk-
wash culture requirement for all elephants (8). 
Knowledge gaps exist about the timing between 
elephant exposure, seroconversion, latent infection, active 
disease, and shedding. To improve medical management 
of elephants and to reduce the risk for transmission to 
other animals and humans, a better understanding of M. 
tuberculosis infection among elephants is crucial. Gaps 
also exist in knowledge regarding treatment and cure 
of elephants with M. tuberculosis infection. Although 
antituberculous medications used to treat humans are 
thought to be effective for treating active TB in elephants, 
little evidence is available to guide decisions regarding 
medication choice, dosage, length of treatment, or 
assessment for cure. Also unclear is whether treatment 
of elephants with M. tuberculosis infection successfully 
prevents progression to active TB disease.
Our ﬁ  ndings highlight the effects of gaps in scientiﬁ  c 
knowledge and provide new information on potential risk 
factors for zoonotic transmission of M. tuberculosis. First, 
in this outbreak the inability to accurately and expeditiously 
detect M. tuberculosis infection and disease in elephants 
contributed to unrecognized, and therefore uncontrolled, 
risk. Improved methods for diagnosis of M. tuberculosis 
infection in elephants are needed. Second, infection control 
practices were insufﬁ  cient to protect employees, creating 
an argument for detailed evidence-based guidelines and a 
more comprehensive approach to implementation. Third, 
employees were largely unaware of the risk for zoonotic 
M. tuberculosis transmission and the need to use adequate 
respiratory protection. Because risk cannot be eliminated, a 
strong occupational health and training program is needed 
for employees who work in facilities that house elephants 
potentially exposed to M. tuberculosis. Finally, our study 
suggests that employees without close contact with 
elephant L were infected through indirect transmission 
of  M. tuberculosis aerosolized during routine barn 
maintenance (i.e., pressure washing or sweeping waste) 
or suspended in shared air. Reasonable efforts to reduce 
aerosol-generating practices and to limit aerosol spread in 
this unique environment should be considered.
The One Health movement argues for integrating 
human and veterinary medicine to defend the health and 
well-being of all animal species (23). This report provides 
a textbook illustration of this need. Captive elephants have 
emerged as an unanticipated source of M. tuberculosis 
infection among humans and therefore must be integrated 
in our strategies to control and eliminate TB. Because 
of the gaps in scientiﬁ  c knowledge, the high prevalence 
of  M. tuberculosis infection among elephants living in 
North America, and the insensitivity of diagnostic tests, a 
substantial need exists for focusing attention on infection 
control practices and occupational health programs 
speciﬁ  cally designed to reduce zoonotic M. tuberculosis 
transmission in the captive elephant industry.
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